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ABSTRACT 
 
The present work presents a fast and sensitive capillary liquid chromatography (µLC) column-
switching method with electrospray ionization time-of-flight mass spectrometry (ESI-TOF-MS) 
detection for the simultaneous determination of dopamine (D), epinephrine (E), norepinephrine 
(NE) and serotonin (SE). A sample volume of 100 µl was loaded on a 25 x 0.32 (i.d.) mm 5 µm 
Hypercarb column at a flow rate of 25 µl/min. The loading mobile phase contained 99.9% H2O 
and 0.1% pentafluoropropionic acid (PFPA) as ion-pairing agent. A water–acetonitrile gradient 
containing 0.1% acetic acid (AcOH) in both reservoirs backflushed the compounds onto a 34 x 
0.32 (i.d.) mm 5 µm Hypercarb analytical column with a flow rate of 5 µl/min. The analytes 
were separated in less than 5 min and the total time for one injection, including reconditioning 
was only 22 min. The analytes were detected in positive ion modus with the molecular ion 
masses [M+H]+ of 154.1, 184.1, 170.1 and 177.1 for D, E, NE and SE, respectively. 
Additionally fragments of masses [M+H-17]+ for D and SE and [M+H-18]+ for E and NE were 
used for detection. The limit of detection (LOD) was 1.5 ng/ml, 0.75 ng/ml, 3.0 ng/ml and 1.5 
ng/ml for D, E, NE and SE, respectively. The method was validated using a concentration 
range of 7.5–70 ng/ml for D, 3.0–70 ng/ml for E and 10–125 ng/ml for NE and SE. The 
calibration curves had R2-values of 0.992, 0.997, 0.985 and 0.998 for D, E, NE and SE, 
respectively. The within-day (n = 3) and the between-day (n = 3) precision of the retention 
times were in the range of 0.7–5.9% and 1.2–3.7%, respectively. The within-day (n = 3) and 
the between-day (n = 3) precision of the peak areas was in the range of 4.8–59% and 8.0–
72%, respectively.  
 
Limitations of the stationary phase material and efforts to eliminate oxidation of both the 
stationary phase and the analytes are discussed. 
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1. Introduction 
 
 
Neurons are nerve cells in the brain, muscle or gland. They receive and evaluate information 
from other neurons or receptor cells as well as pass on information to nerve cells. Neurons 
transmit information by nerve impulses, short breakdowns of the resting potential because of 
changes in the ion balance along their axons. At the ends of an axon these electrical signals 
result in the release of chemical messenger substances, the neurotransmitters. The 
neurotransmitters are transported through the synaptic gap to the dendrite of the next neuron 
where they interact with receptor sites. A change in the potential is induced starting a new 
signal along the second neuron. A detailed figure in the appendix shows the process (figure 
A10).  
Neurotransmitters have important biological, pharmacological and physiological functions. 
Knowledge about neurotransmitters and their functions is crucial for the understanding of 
circuits in the brain. This helps finding circuits that are responsible for mental disorders as 
Parkinson and Alzheimer’s disease, depression and schizophrenia and the biological basis of 
other mental illnesses. Determination of neurotransmitters helps learning about processes like 
memory storage, attention, sleep, movement, cognition, emotion, learning, hormone and 
blood pressure regulation [1].  
 
 
1.1 Catecholamines 
 
One important group of neurotransmitters are catechol- and indolamines (hereafter for 
simplification called catecholamines). The main sites of catecholamine production are the 
brain, the adrenal medulla and sympathetic neurons [2]. Structural formulas of four 
catecholamines used in this study are shown in figure 1. As can be seen from figure 1, 
catecholamines are small, polar molecules with basic pKa–values. Catecholamines have a 
common structural element, the o-hydroxyphenol which has the trivial name catechol and 
gives them their names. The catechol ring is easily oxidized and catecholamines are light- and 
heat sensitive [2]. Thus, care has to be taken during preparation of solutions of 
catecholamines. Additives such as acetic acid [3] or hydrochloric acid [4] are added during 
preparation of stock solutions. Salts of the sulfurous acid as anti-oxidant can be used except 
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when mass spectrometry (MS) detection has been applied [5-7]. The substituted benzene ring 
gives catecholamines a natural ultra violet (UV) absorbance at about 220 nm.  
 
 NH2HO
HO
        
HO
OH
NH
HO
 Dopamine (D)       Epinephrine (E) 
pKa = 9.41 & 9.99       pKa = 9.60 & 9.16 
 
HO
OH
H2N
HO
         
NH2
N
H
HO
 
Norepinephrine (NE)       Serotonin (SE) 
pKa = 9.57 & 8.30      pKa = 9.96 & 10.31 
Figure 1: Structural formulas of the four catecholamines used in this study and their pKa-values. 
Formulas: ChemDraw Ultra 8.0 (CambridgeSoft Corporation, Cambridge, MA, USA),  
pKa-values: SciFinder Scolar 2004 (American Chemical Society, Washington, DC, USA). 
 
 
1.2 Methods of determination 
 
A review on the determination of catecholamines has recently been published by Peaston and 
Weinkove [2]. 
At acidic pH, separation techniques using ionic species, such as electrophoretic 
techniques are suitable. A capillary electrophoresis (CE) method coupled to electrospray 
ionization – mass spectrometry (ESI-MS) for the determination of catecholamines has been 
described by Peterson et al. [4, 8]. However, liquid chromatography (LC) has been the main 
technique for the determination of catecholamines using reversed-phase or ion-pairing as the 
main separation principle. Many different LC methods for determination have been described, 
an indication that none are ideal even with detection methods capable of low detection limits. 
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At acidic pH, separation principles using ionic interactions (ion-exchange chromatography) 
can be applied as well. Some articles using this separation principle have been published [9].  
For the detection of catecholamines, several methods can be used. UV detection suffers 
from poor sensitivity and is not selective enough. To enhance sensitivity and selectivity, 
derivatization can be made to obtain fluorescent or chemiluminescent properties of the 
molecules. Numerous derivatization reagents and techniques have been reported [10-13]. 
Yoshitake and co-workers describe the determination of catecholamines and their metabolites 
in rat brain extracts using fluorescent detection and derivatization with benzylamine and 1,2-
diphenylethylenediamine [10]. Ragab et al. use 1,2-bis(3-chlorophenyl)-ethylenediamine to 
obtain chemiluminescent molecules [11]. The oxidation properties of the catecholamines can 
be used for their detection. Numerous articles describe the determination of catecholamines 
with electrochemical (EC) detection [5-7, 14, 15]. The limits of detection for these methods 
vary, but high sensitivity is achieved in several methods. Best sensitivity in electrochemical 
detection requires optimal operation conditions of the electrochemical detector, and the mobile 
phase has to be conductive, restricting the choice of its composition.  
MS has become more and more popular as detection method [3, 4, 8, 16]. It has the 
advantage of being specific and offers the possibility of structural determination. On the other 
hand, MS methods suffer of poorer sensitivity than obtained with some methods using EC.  
 
 
1.3 Micro – liquid chromatography 
 
Microcolumn LC (µLC) was introduced by Horváth et al. in 1967 [17]. A review on µLC is given 
by Vissers [18], who describes theoretical and historical aspects as well as recent 
developments in µLC both concerning column and instrumental development. A recent article 
dealing with capillary columns was written by Takeuchi [19]. Both articles describe advantages 
of µLC over conventional LC. The smaller inner diameter of capillary columns (e.g. 300 µm) 
results in increased mass sensitivity. Because of the narrow diameter lower flow rates are 
used, making coupling to MS-detection without flow splitting easier and, because of lower 
consumption of mobile phase, exotic eluents can be used. The decrease in column diameter 
also gives rapid response to changes in temperature. Dilution on the column is reduced and 
thus the analyte concentration in the peak increases resulting in increased sensitivity. Smaller 
injection volumes are used, making it attractive for samples with limited access. Care has to 
be taken to minimize all connections and volumes in the injector and detector. 
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1.4 Large volume injections 
 
One problem with µLC is the loss in detection sensitivity due to small injection volumes which 
is required to get high efficiency. However in µLC, larger volumes can be injected using 
column-switching methods based on on-column focusing on a precolumn and still maintaining 
the chromatographic efficiency. On-column focusing occurs when the solutes are dissolved in 
a non-eluting solvent [20, 21]. The solutes are concentrated in a narrow band at the entrance 
of a precolumn and are then backflushed onto an analytical column. The retention on the 
analytical column should be relatively higher than on the precolumn to obtain refocusing of the 
analytes at the column inlet. The concentration step on the precolumn can simultaneously 
provide sample purification since compounds that are not retained on the column are eluted 
into waste. Thus, such a column-switching method is desirable for complex brain samples.  
 
 
1.5 Hypercarb stationary phase 
 
Porous graphitic carbon was introduced as stationary phase (SP) for LC by Knox et al. in 1982 
[22]. The stationary phase is now available under the trade name Hypercarb.  
Hypercarb has great advantages over silica based stationary phases [23]: no swelling, 
shrinking or dissolution is observed with the use of aggressive eluents or 100% water mobile 
phases; it is stable in the entire pH-range; extreme conditions such as high salt concentrations 
or high temperature can be used; it has normal phase as well as reversed-phase properties.  
Porous graphitic carbon stationary phases offer different retention mechanisms than C18 
stationary phases [24]. The compounds are retained by complimentary mechanisms, e.g. 
hydrophobic and electronic interactions. Charge induced interactions e.g. electron-pair donor-
acceptor and dipole-dipole induced types of interaction of the polarizable or polarized 
functional groups of the analyte with the polarizable stationary phase are believed to be the 
most important electronic interactions. The delocalization of the π-electrons in the graphite and 
the high polarizability of the carbon are responsible for dispersive interactions between the 
analyte and the stationary phase [24]. When stereochemistry forces the polar groups of the 
analytes to be close to the graphite surface, dispersion is particularly strong and the retention 
is influenced. Porous graphitic carbon consists of sheets of hexagonally arranged carbon 
atoms with sp2 hybridisation, which results in strong π-π interactions with analytes containing 
aromatic rings. Thus, analytes containing aromatic rings are better retained than on a C18-
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material. Hennion et al. [24] concluded that for the retention of benzene rings with polar 
substituents electronic interactions are more important than hydrophobic interactions. 
These retention mechanisms make Hypercarb attractive for the separation of polar 
compounds. A review of the separation of polar compounds on carbon stationary phase is 
given by Hanai [25]. Separation of inorganic ions [26-28] and positional and optical isomers 
[29, 30] have also been demonstrated.  
 
 
1.6 Electrospray – time-of-flight – mass spectrometry 
 
Mass spectrometric methods are specific, which makes them attractive in methods for 
analysis of samples containing a great variety of compounds, where not all of the analytes can 
be separated. Mass spectrometry provides an extra separation dimension to the method. 
Additionally, MS can provide structural information. 
Electrospray ionization is a soft ionization technique. It is mainly used for charged analytes 
in a solution (e.g. the mobile phase). The main masses observed in an ESI mass spectrum 
using positive mode are the protonated molecular masses [M+H]+. For higher molecular 
weight compounds, multiply charged masses are observed ([M+nH]n+) [31]. Fragments and 
cluster ions (Na, K, formate, acetate) occur as well. 
The time-of-flight mass analyzer detects all ions simultaneously. Extracted ion 
chromatograms (EICs) can be obtained form the total ion current (TIC). The time-of-flight 
mass analyzer achieves high speed; it has a good precision, high resolution and is suitable for 
molecules with high molecular weight [32]. 
 
 
1.7 Aim of study  
 
Brain samples are complex and the concentration of catecholamines is low compared to other 
compounds. A concentration of catecholamines in rat brain tissue of up to 50-100 pg/ 20 mg 
brain has been reported [33]. Thus a method that is both sensitive and can separate a 
complex sample has to be used for their determination. A µLC method with large volume 
injection coupled to MS detection would be a suitable method. 
The aim of this study was to develop a µLC column-switching method for the determination 
of low concentrations of dopamine, epinephrine, norepinephrine and serotonin in rat brain 
samples with ESI-MS as detection method.  
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In a two-dimensional method developed by Storbråten [34] for the determination of 
neuropeptides in rat brain samples, compounds with little retention on the reversed-phase 
precolumns of the second dimension were eluted to waste. These waste-fractions containing a 
lot of small, polar compounds have to be analyzed with a separate method. Originally, the goal 
was to develop a method for the determination of the compounds in these fractions. Since not 
all of the analytes of interest could be concentrated on the precolumn, it was decided to focus 
on catecholamines only. Unfortunately, problems with oxidation of both the stationary phase 
as well as the analytes halted the development of the method. Efforts were focused upon 
suppressing or preventing of oxidation to get a repeatable method. Therefore, analysis of real 
samples is not included in this study. The problems and limitations with the use of Hypercarb 
stationary phase are addressed.  
 
 
2. Experimental 
 
2.1 Reagents  
 
Dopamine (D, 3-hydroxytyramine hydrochloride), epinephrine (E, (-)-epinephrine), 
norepinephrine (NE, (-)-arterenol, ≥98%) and serotonin (SE, 5-hydroxytryptamine maleate 
salt) were obtained from Sigma-Aldrich (St. Louis, MO, USA). 
Grade 1 water was obtained from a Milli-Q ultrapure water purification system (Millipore, 
Bedford, MA, USA). For validation of the method, water was purchased from Fluka (Buchs, 
Switzerland). 
HPLC grade acetonitrile (AcN) from Rathburn (Walkerburn, UK), sds (Peypin, France) or 
LabScan (Dublin, Ireland) was used. Methanol (MeOH, HPLC grade) was obtained from BDH 
Hipersolv (Poole, England). Tetrahydrofuran (THF, HPLC grade) was purchased from sds. 
Acetic acid (AcOH, 100% analytical grade), trifluoroacetic acid (TFA, spectroscopic 
quality), ascorbic acid (≥ 99.7%, analytical grade), sodium thiosulphate (99.5-100.5%, 
analytical grade), hydrochloric acid (37% fuming, analytical grade) and benzoic acid (99.9%, 
analytical grade) were obtained from Merck (Darmstadt, Germany). 
Pentafluoropropionic acid (PFPA, ≥ 97%), formic acid (FA, 50%, analytical grade) and 
ammonium formate (≥ 99.0%, puriss analytical grade for MS) were purchased from Fluka. 
Heptafluorbutyric acid (HFBA, ≥98%) was obtained from Sigma-Aldrich.  
Nitrogen (2.0, 99.99%) and helium (4.6, 99.996%) were purchased from AGA (Oslo, Norway). 
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2.2 Instrumentation 
 
2.2.1 Column – switching system 
 
A sketch of the µLC system is shown in figure 2.  
All capillaries were either fused silika capillaries purchased from Polymicro Technologies 
(Phoenix, AZ, USA) or PEEK tubing (Upchurch scientific, Oak Harbor, WA, USA). Various 
dimensions and lengths were used throughout the system, they are shown in figure 2. 
Capillary connections were made with Valco Instruments Co. (Houston, TX, USA) ZU1C 
unions, Valco FS1.4 polyimide ferrules and Valco 2SR1 steel screens. The injector was a 
Rheodyne (Cotati, CA, USA) 7010 6 ports injector (valve I). External sample loops with 
volumes of 25, 50, 100 and 200 µl were prepared from PEEK tubing. A 250 µl laboratory 
syringe from SGE (Ringwood, Victoria, Australia) was used as injection syringe. A ChemInert 
2-position 6-port micro-valve (C2-1036) from Valco served as a column-switching valve (valve 
II). The loading mobile phase was delivered at a flow rate of 25 µl/min by a LC-10AD VP 
double head isocratic pump from Shimadzu Corporation (Kyoto, Japan). An Agilent 1100 
capillary gradient pump (Palo Alto, CA, USA) with an incorporated on-line vacuum degasser 
was used to deliver the separation mobile phase. The flow rate of the separation mobile phase 
was 5 µl/min. The outlet of the analytical column was connected via an union which served as 
grounding point to a Micromass (Manchester, UK) LCT orthogonal accelerated TOF-MS. The 
TOF-MS was equipped with a Z-spray atmospheric pressure ionization source for ESI, which 
was modified with a spray capillary of 25 µm i.d. to handle flow rates in the low µl/min range. 
Electrospray ionization was performed in the positive mode and the applied voltages are 
shown in table 1. A more detailed description of the MS-conditions is given in table A4 in the 
appendix. 
 
Table 1: Applied MS–voltages. 
Part Voltage [V] 
Spray capillary 2800 
Sample cone 15 
Extraction cone 3 
RF lens 200 
 
The source temperature was 100°C. The desolvation gas flow rate was ~250 l/h. The mass-to-
charge-ratio (m/z) range during acquisition was set to 135 – 195. The TOF-MS instrument was 
controlled and data were acquired using MassLynx version 4.0 software (Micromass). 
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In-line UV detection was performed with a WellChrom K-2600 UV detector (Knauer, Berlin, 
Germany) equipped with a SunChrom (Friedrichsdorf, Germany) 10 mm, 0.045 µl SC-Cap-
flow cell.  
All voltametric measurements were made with a Fluke (Everett, WA, USA) 73 Series II 
multimeter. 
 
 
 
Figure 2: Sketch of the column-switching system. Yellow: Fused silika capillaries; brown: PEEK tubing; 
grey: steel tubing; 030 = 30 µm i.d.; 050 = 50 µm i.d.; 100 = 100 µm i.d.  
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2.2.2 Simplified instrumentation 
 
During parts of the method development a simplified system was used. A sketch of the system 
is shown in figure 3. A Valco ChemInert C4-0004-.05 injection valve with an internal 50 nl loop 
was used as injection valve. The gradient pump delivered mobile phase with a flow rate of 5 
µl/min. Only the analytical column was used. Detection was performed by (+) ESI-MS. 
 
 
 
Figure 3: Sketch of the simplified system.  
 
 
2.3 Columns and column packing 
 
Dimensions of the columns used in the system are shown in table 2. In addition, three 
columns tested as possible precolumns are included (marked *). 
 
Table 2: Dimensions of the Hypercarb columns used in the final system and column dimensions of 
three different precolumns. 
Column type i.d. [mm] o.d. [mm] 
Length 
[cm] 
Pore size 
[Å] 
Particle size 
[µm] 
Precolumn  0.32 0.45 2.5 250 5 
Analytical column  0.32 0.45 3.4 250 5 
Guard column I 0.32 0.45 ~ 3 250 5 
Guard column II 0.32 0.45 ~ 2.5 250 5 
*Kromasil C18  0.32 0.45 4 100 10 
*Hypercarb 0.32 0.45 4 250 5 
*PS-DVB 0.2 not known 5 monolithic monolithic 
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Hypercarb batch PGC 221, 5 µm (Thermohypersil, Chesire, UK) was used as stationary 
phase material in all Hypercarb columns. The Kromasil material was obtained from Eka Nobel 
(Bohus, Sweden). The polystyrene-divinylbenzene column was purchased from LC Packings 
(Amsterdam, The Netherlands). The columns were slurry packed using a mixture of AcN and 
grade 1 water (70/30, v/v) as packing fluid. About 30 mg packing material was suspended in 
200 µl carbon tetrachloride and kept in an ultrasonic bath for 10 min to get a proper 
suspension. The suspension was introduced into a metal tubing (packing chamber) connected 
via a Valco ZU1C union to a fused silica capillary with a length of about 5-7 cm. The other end 
of the capillary was again connected to a union with a Valco 2SR1 frit to keep the packing 
material inside the capillary. The top of the packing chamber was connected to an ISCO 
100DM syringe pump. The pump was programmed to start at 100 bar and increase the 
pressure at a rate of 200 bar/min to 650 bar. At 650 bar, the column was conditioned for 20 
min. After the conditioning step the pump was disconnected with a valve. The column was 
allowed to depressurize for another 20 min. The pressure in the system was decreased by 
another program starting at 650 bar with a rate of -100 bar/min to 1 bar. After this the column 
was disconnected and cut into appropriate lengths.  
 
 
2.4 Preparation of solutions  
 
All solutions containing catecholamines were prepared in Plastibrand PP 1.5 ml plastic vials 
(Brand GMBH, Wertheim, Germany) or in 20 ml PE vials (Zinsser, Frankfurt, Germany). 
Microliter pipets were always used to deliver microliter volumes. 
 
 
2.4.1 Mobile phases 
 
Mobile phases for the loading of samples were prepared using a measuring cylinder; mobile 
phases for the analytical separation were prepared using glass volumetric flasks. Table 3 
shows the mobile phases used in the final method and during testing of the precolumns. In the 
final method, the mobile phases were de-gassed with helium for ~15 min prior to use.  
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Table 3: Mobile phases. 
Type Mobile phase Type Mobile phase 
loading 99.9% H2O + 0.1% PFPA test precolumn (A1) 99.9% H2O + 0.1% AcOH 
separation (A) 99.9% H2O + 0.1% AcOH test precolumn (B1) 99.9% AcN + 0.1% AcOH 
separation (B) 99.9% AcN + 0.1% AcOH test precolumn (A2) 99.9% H2O + 0.1% HFBA 
 test precolumn (B2) 50% AcN + 0.1% HFBA 
 
 
2.4.2 Stock solutions 
 
1 mg/ml stock solutions of each of the four catecholamines were prepared by dissolving 1 mg 
of substance in 1 ml 50:50 H2O:0.1 M HCl (v/v). The stock solutions were stored in darkness 
at -20°C and had a shelf life of at least a month [4].  
 
2.4.3 Direct infusion solutions 
 
Direct infusion solutions of each catecholamine (table 4) for the determination of exact 
molecular masses and the optimization of the ESI-MS conditions were prepared. Each 
solution contained 0.1 mg/ml analyte, an appropriate amount AcN and 0.1% acetic acid to get 
ionization of the test substance and to control the pH. To compare signal-suppressing effects 
of four different ion-pairing agents, four direct infusion solutions containing 0.1% of a 
respective ion-pairing agent, 0.1 mg/ml of each catecholamine and 99.9% water were 
prepared. The direct infusion solutions were stored in darkness at 4°C. 
 
Table 4: Direct infusion solutions for optimization of MS conditions. 
 Dopamine Epinephrine Norepinephrine Serotonin 
Concentration [mg/ml] 0.1  0.1  0.1  0.1  
% AcN 10 10 10 50 
% AcOH 0.1 0.1 0.1 0.1 
 
 
2.4.4 Working solutions and validation solutions 
 
Working solutions for method development were prepared by appropriate dilutions of the stock 
solutions with grade 1 water. Validation solutions were prepared by appropriate dilutions of the 
stock solutions with water from Fluka. Table 5 shows the concentration of working solutions 
and validation solutions. The solutions were stored in darkness at 4°C and could be stored for 
at least a week [2].  
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The linearity test was performed by injecting validation solutions from lowest to highest 
concentration to avoid carry-over: blank, validation solution #1 (n = 3), validation solution #2 (n 
= 1), validation solution #3 (n = 3), validation solution #4 (n = 1), validation solution #5 (n = 3), 
validation solution #6 (n = 1). The within-day and between-day precisions were calculated by 3 
series of validation solutions at three concentration levels (1, 3 and 5, n = 3) on 3 different 
days. A blank was included at the beginning of each series to recondition the system. The 
guard columns were treated with 100 µl 1 M Na2S2O3 and 150 µl water after each day to 
regain their original properties. 
 
Table 5: Concentration of working solutions and validation solutions. 
Solution Concentration [ng/ml] 
 Dopamine Epinephrine Norepinephrine Serotonin 
Working solution 50 nl 104  104 104 104 
Working solution loop 250  250  250  250  
Working solution loop 62.5 62.5 62.5 62.5 
Blank 0 0 0 0 
Validation solution #1 7.5 3.0 10 10 
Validation solution #2 15 6.0 20 20 
Validation solution #3 25 15 30 30 
Validation solution #4 35 30 50 50 
Validation solution #5 50 50 60 60 
Validation solution #6 70 70 125 125 
 
 
2.4.5 Other solutions 
 
A 1 M ammonium formate solution was prepared from solid formic acid ammonium salt. The 
pH was adjusted to 2.9 with formic acid. A 1 M sodium thiosulphate solution was prepared 
from solid sodium thiosulphate (NaS2O3 5H2O). A 1 M ascorbic acid solution was prepared 
from solid L-(+) ascorbic acid and 5 mM benzoic acid was prepared from solid benzoic acid. 
All solutions prepared form salts were filtered through a 0.45 µm filter (Sartorius AG, 
Göttingen, Germany) before use. 
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3. Results and discussion 
 
 
The concentration of catecholamines in brain samples is low compared to other compounds. 
Additionally, brain samples have a complex matrix with a great variety of compounds. Thus a 
selective method with a low limit of detection capable to give separation of a complex sample 
has to be used for the determination of catecholamines in brain samples. Sensitivity is 
achieved by using a µLC column-switching method and ESI-MS which provides both selective 
and sensitive detection and is therefore chosen as detection method. 
 
 
3.1 Mass spectrometric detection 
 
The masses used for detection were determined by direct infusion. Figure 4 shows the mass 
spectra for dopamine (a), epinephrine (b), norepinephrine (c) and serotonin (d). The main m/z 
peaks are the protonated molecular ions, [M+H]+. Fragments of mass [M+H-17]+ due to loss of 
ammonia (- NH3) for D and SE and fragments of mass [M+H-18]+ due to loss of water (- H2O) 
for E and NE were observed as well. The m/z values of the molecular ions and the fragments 
are summarized in table 6.  
Both the molecular ion and the fragment ion are included in the extracted ion 
chromatograms (EICs) and the calculations of peak areas, if not otherwise is stated. 
 
 
Table 6: m/z values of [M+H]+ and m/z values of fragments determined by direct infusion (table 4). 
 Dopamine Epinephrine  Norepinephrine  Serotonin  
m/z [M+H]+ 154.1 184.1 170.1 177.1 
m/z fragment 137.1 166.1 152.1 160.1 
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Figure 4: Mass spectra of direct infusion of catecholamines. a) D, 0.1 mg/ml, 10% AcN, 0.1% AcOH; b) 
E, 0.1 mg/ml, 10% AcN, 0.1% AcOH; c) NE, 0.1 mg/ml, 10% AcN, 0.1% AcOH; d) SE, 0.1 mg/ml, 50% 
AcN, 0.1% AcOH.  
 
 
3.2 Stationary phase considerations 
 
Care has to be taken when ESI-MS detection is used in the work with Hypercarb columns. 
Electrochemical reactions at the grounding point of the backward current from the ESI-spray 
capillary enhance oxidation of the mobile phase, the analytes and the stationary phase 
material. To prevent oxidation of Hypercarb and the analytes by the backward current, a 
grounded stainless steel union has to be coupled between the ESI-spray capillary and the 
analytical column [35]. However, the stationary phase can also slowly be oxidized by some 
oxidizing agents or dissolved oxygen in the mobile phase [36], and care has to be taken to de-
gas all mobile phases. 
Oxidized Hypercarb material has different chromatographic behavior from reduced 
Hypercarb material, as demonstrated by Törnkvist and co-workers [36]. When Hypercarb is 
treated with oxidizing agents, such as permanganate or hydrogen peroxide, the retention 
times of cationic analytes were decreased [37]. Peak splitting of the peaks of easy oxidized 
analytes on an oxidized column was observed as well [35].  
The different behavior of oxidized Hypercarb columns is explained by an alternation of the 
surface properties. The anion-exchange capacity of the Hypercarb column increases with 
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increased concentration of oxidizing agents. Thus exclusion of cationic analytes is exerted by 
the material, resulting in a decrease in retention times. This suggests that Hypercarb may 
have positive surface charge, which can be altered by treatment with redox agents. Treatment 
of Hypercarb with oxidizing agents increases the surface positive charge, explaining shorter 
retention times of cationic analytes [37]. The charge that the particles have gained was 
however not distributed evenly throughout the column. Thus, it was assumed that the redox 
reactions occurring on the Hypercarb column were caused by some functional groups on the 
surface of the stationary phase material that were altered by redox reactions [36]. When the 
column is exposed to oxidizing agents, a slow change of the Hypercarb material due to 
oxidation of these functional groups occurs. The effect of oxidation of Hypercarb lasts longer 
than the effect of reducing agents [37].  
 
 
3.2.1 Precolumn 
 
In order to obtain sufficient focusing of the polar catecholamines, a stationary phase which 
provides high retention of the compounds has to be used. Three different materials were 
considered as stationary phase, a C18-material (Kromasil), porous graphitic carbon 
(Hypercarb) and monolithic polystyrene-divinyl benzene (PS-DVB). The Kromasil C18-material 
was chosen because it was shown to provide most retention of the five different C18-materials 
tested in preliminary experiments (appendix, chapter 6.1.1).  
In a column-switching system it is crucial that the analytes are fully retained on the 
precolumn for their complete preconcentration. Thus breakthrough of various analytes on the 
precolumns was tested with a mobile phase containing an ion-pairing agent. The procedure is 
illustrated in figure 5. A more detailed description of experimental parameters and a table of all 
compounds tested are given in table A3 in the appendix.  
Table 7 shows the conditions under which the catecholamines could be focused. 
Hypercarb turned out to be the best suitable stationary phase for concentration of the 
catecholamines on the precolumn. However, even on the Hypercarb column, AcOH did not 
give enough retention of D, E and NE, thus a more hydrophobic ion-pairing agent, had to be 
used for concentrating on the precolumn. 
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Table 7: Conditions for concentration of catecholamines on precolumns tested. 
  Dopamine Epinephrine Norepinephrine Serotonin 
AcOH no no no no C18 HFBA no no no no 
AcOH no no no yes (0% AcN*)Hypercarb 
HFBA yes (0% AcN*) yes (0% AcN*) yes (0% AcN*) yes (0% AcN*)
* The numbers in brackets give the minimum percentage AcN that can be present in the MP to get 
focusing of all four analytes. 
 
 
 
Figure 5: Flow chart illustrating the procedure for testing reversed-phase precolumn materials. 
 
 
 
 
 
 
 
Model substances 
Focused on Kromasil C18  
with ACOH? 
Focused → ok Not focused → continue 
Focused on Kromasil C18 
with HFBA?   
Focused → ok Not focused → continue
Focused on Hypercarb 
with ACOH? 
Focused → ok Not focused → continue 
Focused on Hypercarb 
with HFBA? 
Focused → ok Not focused → continue 
Focused on PS-DVB 
with HFBA? 
 Focused → ok Not focused  
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3.2.2 Analytical column 
 
After backflushing from the precolumn it is advantageous to use a stationary phase in the 
analytical column which gives slightly higher relative retention than the precolumn. The 
Hypercarb material was only available in two particle sizes, 7 µm and 5 µm at the time. Thus, 
a particle size of 7 µm would have been desirable to use in the precolumn and to refocus the 
analytes on the analytical column (5 µm particles). However the 7 µm batch was severely 
contaminated with smaller, irregular sized particles, and could not be used as precolumn 
material [38]. Therefore, both the analytical column and the precolumn consisted of Hypercarb 
stationary phase material of the same particle size, 5 µm. 
 
 
3.3 Mobile phase considerations 
 
3.3.1 Separation mobile phase 
 
The separation mobile phase was found using the simplified system (figure 3). 
The most common organic modifiers used in liquid chromatography are methanol 
(MeOH), AcN and tetrahydrofuran (THF). MeOH and THF give higher backpressure due to 
higher viscosity in water mixtures than AcN. Since 3 columns are coupled in series during 
elution and separation in the final method, high backpressure is a problem with water/MeOH 
and water/THF mixtures. The highest pressure observed during analysis with a water/AcN 
mobile phase was ~250 bar. Thus MeOH and THF were not suitable in the final system.  
An ion-pairing agent had to be added to the mobile phase to give high enough retention. 
Additionally, the mobile phase for ESI-detection of basic compounds should be acidic (two 
units below pKa) to get ionization of the analytes and pH-control. AcOH, trifluoroacetic acid 
(TFA), pentafluoropropionic acid (PFPA) and HFBA were compared as possible ion-pairing 
agents. Direct infusion solutions were introduced into the MS and the extracted ion 
chromatogram yielded the signal intensities. The values of the signal intensities are shown in 
table 8.  
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Table 8: Signal intensities of m/z-values of the catecholamines with four different acids used as ion-
pairing agents determined by direct infusion with a solution containing 0.1 mg/ml catecholamines. The 
intensities were obtained from EIC. 
 Signal intensities [arbitrary units] 
Ion-pairing agent Dopamine Epinephrine Norepinephrine Serotonin 
AcOH 22700 23500 13900 13800 
TFA 907 999 707 540 
PFPA 1260 1290 901 775 
HFBA 2200 2810 1530 1190 
 
Severe signal suppression was observed with TFA as ion-pairing agent. This has been 
described before [39], but the effect differs from instrument to instrument and analyte to 
analyte. PFPA gave severe signal suppression for NE and SE, while only moderate for D and 
E. HFBA gave moderate signal suppression for all four analytes. Formic acid (FA) could be an 
alternative, but better chromatographic peak shape is achieved with AcOH as ion-pairing 
agent.  
Gradient elution was performed to separate the catecholamines on the analytical column. 
Gradient elution is in this case preferred over isocratic elution because of the great difference 
in retention times of the four catecholamines. D, E and NE have similar retention times, while 
SE has much higher retention. By applying a gradient, much better peak shape for SE was 
achieved and the chromatographic time was reduced.  
The unique retention mechanisms of Hypercarb columns induce an elution of each 
catecholamine from the column at a specific amount AcN. The interaction strength of the 
catecholamines with the graphite is dependent of the molecular area in contact with the 
column surface. The planar structure of the catecholamines gives a strong interaction, which 
only can be broken with a specific amount AcN. Thus, sharp peaks are obtained as can be 
seen in figure 6.  
 In table 9 the best separation gradient is presented. NE, E and D are eluted in the linear 
gradient of the first 2.5 min. SE is eluted in the 50% B step.  
 
Table 9: Best separation gradient. A = 99.9% H2O+0.1% AcOH. B = 99.9% AcN+0.1% AcOH.   
Time [min] % B  
00.00 0 initial condition, start ramp 
02.50 10 end ramp 
02.51 50 
05.00 50 elution SE 
05.01 100 
10.00 100 column wash (precolumn and analytical column) 
10.01 0 
15.00 0 reconditioning* (analytical column) 
* The precolumn is reconditioned with 0% B for 2 min before the reconditioning with the 
loading MP starts. 
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A chromatogram using this gradient is shown in figure 6. The elution order is NE; E; D; SE. 
 
Figure 6: EIC of the separation of catecholamines using gradient elution on a 50 x 0.32 mm (i.d.) 5 µm 
Hypercarb column. The MP consisted of H2O+0.1% AcOH (A) and AcN+0.1% AcOH (B) with a flow rate 
of 5 µl/min. The injection volume was 50 nl and the sample concentration 0.1 mg/ml of each 
catecholamine.   
 
 
3.3.2 Loading mobile phase 
 
To focus the catecholamines on the precolumn, a mobile phase consisting of 100% water 
added a suitable ion-pairing agent is needed, since small amounts AcN elute the analytes. 
Four acids, AcOH, TFA, PFPA and HFBA were tested as ion-pairing agents. 
AcOH did not give enough retention of D, E and NE on the precolumn (chapter 3.2.1), thus 
a more hydrophobic ion-pairing agent had to be utilized. In the method developed by 
Storbråten [34], TFA is used to dilute the fractions from the first dimension. Thus, TFA in the 
loading mobile phase would have been ideal with regard to analyzing waste fractions 
originating from that method.  
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However, a low signal intensity was obtained for NE with 0.1% TFA in the loading mobile 
phase. By changing to 0.1% HFBA, the intensity of the NE signal was improved (figure 7). 
Thus it appears that TFA is not hydrophobic enough to provide satisfactory focusing of NE on 
the precolumn. The intensity of the SE signal was lower with HFBA than with TFA (not 
shown). This may be due to ion-pair binding of SE with HFBA which might be too strong and 
therefore the HFBA anion cannot be exchanged by AcOH used in the separation mobile 
phase. This might also be the reason for the somewhat higher retention observed for NE 
(figure 7). The amount HFBA was decreased to get a better exchange of the two ion-pairs, but 
no improvement was achieved. The use of 0.1% PFPA improved both the intensity of NE 
(figure 7) and SE, and thus PFPA was chosen as ion-pairing agent in the loading mobile 
phase. 
 
 
 
Figure 7: EIC showing the effect of the loading MP ion-pairing agent on signal intensity of 
norepinephrine. a) TFA; b) HFBA, c) PFPA.  
The SP of both columns was Hypercarb. A sample concentration of 250 ng/ml was used and the 
sample loop had a volume of 25 µl. The loading MP had a flow rate of 20 µl/min. The separation MP 
consisted of H2O/AcN added 0.1% AcOH with a flow rate of 5 µl/min.  
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3.4 Separation of catecholamines on Hypercarb material 
 
During development of the separation gradient (chapter 3.3.1), numerous injections were 
performed on a freshly packed column using the simplified system and water/acetonitrile 
containing 0.1% AcOH as separation mobile phase. The mobile phase was not degassed at 
that time and the column was grounded as proposed by Törnkvist and co-workers [35] to 
avoid oxidation of the analytes. No oxidation of the analytes was observed even though large 
amounts mobile phase were pumped through the column. 
However, when using the column-switching system, after some injections a low intensity 
was observed for the peaks of E and SE in the EIC (figure 8). The analytical column was 
tested with the simplified method, and the EIC revealed four peaks with high intensity 
corresponding to the catecholamines (figure 9a). Then the precolumn was tested in the same 
way, and only two peaks were observed in the EIC (figure 9b). The mass spectra of the peaks 
in figure 9b revealed most abundant masses of m/z = 170 (NE) and m/z = 154 (D). 
 
 
 
Figure 8: EIC of an injection in the column-switching system showing low signal intensity of the peaks 
of E and SE.  
The SP of both columns was Hypercarb. A sample concentration of 250 ng/ml was used and the 
sample loop had a volume of 25 µl. The loading MP consisted of H2O+0.1% PFPA with a flow rate of 20 
µl/min. The separation MP consisted of H2O/AcN added 0.1% AcOH with a flow rate of 5 µl/min. 
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Figure 9: EIC of injections of catecholamines on the Hypercarb analytical column (a) and the 
Hypercarb trap column (b).  
The MP consisted of H2O/AcN added 0.1% AcOH with a flow rate of 5 µl/min. The injection volume was 
50 nl and the sample concentration 0.1 mg/ml of each catecholamine.   
 
 
Obviously, some processes had occurred on the trap column in the column-switching system, 
since E and SE could not be detected with high intensity. Since the column was grounded it 
was not believed that oxidation had occurred. It was supposed that some irreversible 
processes involving the ion-pairing agent and the two analytes had occurred. An UV-detector 
was coupled in-line with the MS, to check if E and SE eluted from the precolumn. Four peaks 
were observed in the UV-chromatogram (Figure 10). Thus, some process on the column had 
altered the masses of at least E and SE. 
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Figure 10: UV chromatogram of the column-switching method.  
The SP of both columns was Hypercarb. A sample concentration of 250 ng/ml was used and the 
sample loop had a volume of 25 µl. The loading MP consisted of H2O+0.1% PFPA with a flow rate of 20 
µl/min. The separation MP consisted of H2O/AcN added 0.1% AcOH with a flow rate of 5 µl/min. 
 
 
Since no problems with detection were observed during the gradient tests (chapter 3.3.1), the 
retention times and signal intensities repeatability on the analytical column was tested with the 
simplified method in the same manner as during separation mobile phase evaluation. Figure 
11 shows the chromatogram (TIC) for the first and fifth injection. After five injections, the E 
peak (2nd peak) had nearly disappeared, while a peak with a retention time close to SE was 
observed (figure 11b).  
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Figure 11: TIC of the first (a) and fifth (b) injection of a mixture of catecholamines on the analytical 
Hypercarb column alone. The MP consisted of H2O/AcN added 0.1% AcOH with a flow rate of 5 µl/min. 
The injection volume was 50 nl and the sample concentration 0.1 mg/ml of each catecholamine. 
 
 
Mass spectra of the compounds eluted in the four peaks observed in the TIC were obtained. 
They revealed the most abundant m/z-values of the peaks in the first injection were m/z = 
170.1 (NE, 1st peak), m/z = 184.1 (E, 2nd peak), m/z = 154.1 (D, 3rd peak) and m/z = 191.1 (4th 
peak) (figure 12). The most abundant m/z-values of the peaks observed in the TIC of the 5th 
injection were m/z = 168.1 (1st peak), m/z = 152.1 (2nd peak), m/z = 180.1 (3rd peak) and m/z = 
191.1 (4th peak) (figure 13). 
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Figure 12: Mass spectra of the a) 1st peak, b) 2nd peak, c) 3rd peak, d) 4th peak observed in the TIC of 
the first repeatability test. m/z values of the catecholamines are marked with red. 
 
 
 
Figure 13: Mass spectra of the a) 1st peak, b) 2nd peak, c) 3rd peak, d) 4th peak observed in the TIC of 
the first repeatability test. The most abundant m/z-values are marked with red. 
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Injections of solutions containing only one of the catecholamines (figure 14) revealed that the 
1st peak corresponded to NE ([M+H-2]+), the 2nd to D ([M+H-2]+), the 3rd to E ([M+H-4]+) and 
the 4th to SE ([M+H+14]+).  
 
 
 
Figure 14: EIC (a-d) of injection of a solution containing D, E, NE or SE, respectively on the analytical 
Hypercarb column. TIC of the 5th injection on the analytical column (e, figure 11b). The MP consisted of 
H2O/AcN added 0.1% AcOH with a flow rate of 5 µl/min. The injection volume was 50 nl and the sample 
concentration 0.1 mg/ml of each catecholamine. 
 
 
The m/z-values found suggested that oxidation of the catecholamines had occurred even 
though the column was grounded and no electrical current was measured over the column. 
The structures and masses of the oxidized catecholamines are given in figures 15-18. E is 
oxidized to adrenoquinone (m/z = 182) and leucoadrenoquinone (m/z = 180). 
Leucoadrenoquinone contains a double ring, thus an increase in retention time was observed 
(figure 11). The m/z–value of 191 for SE is believed to be indol-quinone as shown in figure 18 
with an addition of one oxygen-atom to the molecule. A similar addition of oxygen has been 
observed for the amino acid tryptophane in water samples [40]. 
 
 
 
 35
NH2HO
HO
+ 150 mV vs. Pd
- 150 mV vs. Pd
O
O
+ 2e-  +2H+
 m/z ([M+H]+) = 152Dopamine, m/z ([M+H]
+) = 154.1
NH2
 
Figure 15: Oxidation of dopamine [41].  
(ChemDraw Ultra 8.0 (CambridgeSoft Corporation, Cambridge, MA, USA)) 
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Figure 16: Oxidation of norepinephrine [41].  
(ChemDraw Ultra 8.0 (CambridgeSoft Corporation, Cambridge, MA, USA)) 
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Figure 17: Oxidation of epinephrine [42]. 
(ChemDraw Ultra 8.0 (CambridgeSoft Corporation, Cambridge, MA, USA)) 
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Figure 18: Oxidation of serotonin [41].  
(ChemDraw Ultra 8.0 (CambridgeSoft Corporation, Cambridge, MA, USA)) 
 
As mentioned in chapter 3.2, it was believed, that oxidation of the Hypercarb material was 
caused by oxidation of functional groups on the surface of the stationary phase. The charge 
that the particles have gained during oxidation was not distributed evenly throughout the 
column. Since the oxidation of D and NE is reversible, they should be oxidized in one part and 
reduced in another part of the column.  
However, it is shown that D was affected by the oxidized stationary phase. After 2-3 
injections on the column, most D eluted as the quinone with molecular ion [M+H-2]+ (figures 
13 and 15) When the mobile phase used by Törnkvist and co-workers (MeOH:50 mM 
ammonium formate buffer (pH 2.9) 60:40 (v/v)) [16] was applied, oxidation of the 
catecholamines was observed as well. On the other hand, a newly packed Hypercarb column 
could be used with the separation mobile phase for several weeks without observing 
oxidation. However, once the columns were used in the column-switching system, the 
catecholamines were oxidized.  
The observations suggested that the entire precolumn was oxidized by the loading mobile 
phase in an irreversibly way. Even though the column was treated with sodium thiosulphate, 
after some injections the compounds were oxidized. Oxidizing agents in the mobile phase can 
oxidize Hypercarb columns. In the present study, fluorinated acids were used and these types 
of mobile phase additives have not been used by others.  
With compounds that have electron-donating or –accepting properties, graphite forms 
reversible electrovalent compounds with simultaneous exchange of charge [43]: 
 
−+ eC
x
n
x    [ ]xnCx −1   electron-donor    (1) 
xCx
n
  [ ] −+ + eC
x xn
1
  electron-acceptor    (2) 
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Fluorinated acids are electron-accepting compounds and can thus form electrovalent 
compounds with graphite according to (2). The graphite gets a positive charge which 
corresponds to the observations by Shibukawa [37]. Since this process is reversible, it cannot 
be used to explain the behavior of the Hypercarb stationary phase material observed in the 
present study. 
Graphite can react with oxidizing acids to form covalently or ionic bounded graphite-
compounds. In these graphite-compounds, elements like fluorine or oxygen are deposited in 
the graphite forming electron-pairing bounds to carbon atoms [43]. Alternatively, graphite can 
be oxidized to ionic graphite salts by strong acids in the presence of oxidizing agents [43]. 
PFPA has a pKa-value of 0.18. Dissolved oxygen in the mobile phase could be a potential 
oxidizing agent.  
Both theories can be used to explain the irreversible oxidation of all catecholamines. The 
properties of the stationary phase material may have changed over the entire column. 
Because of the mentioned reactions of graphite, there may be no differences in oxidation 
behaviour in parts of the column as described in literature [36, 37]. The formation of a salt or a 
covalently bounded compound may be irreversible and this could explain why a column 
exposed to fluorinated acids never gained its original properties even though it was treated 
with reducing agents. 
 
 
3.4.1 Prevention of oxidation 
 
3.4.1.1 Considerations for loading mobile phase and trap column 
 
Some precautions to prevent oxidation have been mentioned in chapter 3.2. To prevent the 
oxidation of the column by mobile phase additives, alternatives to both the loading mobile 
phase and the precolumn have been considered. Avoiding fluorinated acids in the loading 
mobile phase leaves pentanoic acid or benzoic acid as alternative since hydrophobic ion-
pairing agents are needed to provide high enough retention. Since benzoic acid contains a 
benzene ring, it could possibly give high retention on Hypercarb. However, bad peak shape 
was obtained when benzoic acid was used as ion-pairing agent (figure 19). The pka of benzoic 
acid is similar to that of AcOH (4.20 vs. 4.79). One reason for the bad peak shape could be 
that AcOH could not exchange efficiently with the benzoic acid ion-pair, and this results in 
different retention on the analytical column for parts of the analyte. Pentanoic acid has a pka-
value of 4.78, which is about the same as AcOH. Thus it was also anticipated that AcOH could 
not exchange with pentanoic acid in an ion-pair.  
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Figure 19: EIC of SE (m/z = 191), NE (m/z = 168), E (m/z = 180), D (m/z = 152) when 5 mM benzoic 
acid is used as ion-pairing agent in the loading MP. The SP of both columns was Hypercarb. A sample 
concentration of 250 ng/ml was used and the sample loop had a volume of 25 µl. The loading MP had a 
flow rate of 20 µl/min. The separation MP consisted of H2O/AcN added 0.1%AcOH with a flow rate of 5 
µl/min. 
 
Hence, both an ion-exchange column and a packed PS-DVB column were considered as 
precolumn.  
As shown by Storbråten [34], 10% acetonitrile was needed to get elution of the compounds 
from the ion-exchange column. Under these conditions, no refocusing on the Hypercarb 
analytical column would have been achieved for D, E, and NE, since dilution to the initial 
condition of the gradient is impossible. By diluting the eluate from the precolumn, bad peak 
shapes would have been obtained since 100% refocusing on the second column is not given.  
The preconcentration of 0.1 mg/ml catecholamines on a packed PS-DVB column using 
H2O + 0.1% HFBA as mobile phase and an injection volume of 50 nl was not successful. 
 
 
3.4.1.2 Considerations of additives to stock solutions / mobile phase 
 
Efforts were made to prevent oxidation of the catecholamines by adding anti-oxidants to either 
the stock solution or the separation mobile phase.  
Ascorbic acid is a common reducing agent. It is reported that ascorbic acid interferes in 
voltammetric determinations of D [44], thus it might be easier oxidized than the 
catecholamines. Additionally, ascorbic acid is proposed to be added as antioxidant for sample 
 39
storage [45]. Thus, the stock solution was prepared in 0.1 M ascorbic acid to stabilize the 
sample. Working solutions of D, NE and SE were injected in the simplified system and no 
oxidation of the analytes was observed. SE and ascorbic acid have similar molecular masses 
and figure 20 shows that there was no peak overlapping when SE and a blank containing 
ascorbic acid are injected. No peak was observed in the blank injection, thus the ascorbic acid 
had been oxidized.  
 
 
Figure 20: EIC of an injection of serotonin (a) and a blank containing ascorbic acid (b) on the 
Hypercarb analytical column. The MP consisted of H2O/AcN added 0.1% AcOH with a flow rate of 5 
µl/min. The injection volume was 50 nl and the concentration of serotonin was 0.1 mg/ml. 
 
When a working solution containing all catecholamines was injected, oxidation of D was 
observed in the 2nd injection (figure 21a and b). A working solution containing D was injected 
to confirm oxidation of the compound (figure 21c and d). The working solution was injected 
with the column disconnected to see if oxidation had occurred in the solution, but no oxidation 
was observed (figure 21e). This suggested that the ascorbic acid was oxidized leaving the 
catecholamines in their reduced form in the first couple injections, but when several injections 
were performed the amount of ascorbic acid added to the stock solutions was not enough to 
prevent oxidation of the catecholamines. 0.1 mmol ascorbic acid was added to the A reservoir 
(100 ml) of the separation mobile phase. With ascorbic acid added to the mobile phases SE 
could not be detected since the mass of ascorbic acid [M+H]+ interfered with the mass of SE 
[M+H]+. Thus, ascorbic acid was not suitable for use as mobile phase additive to prevent 
oxidation. The addition of ascorbic acid to the loading mobile phase was not tried. 
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Figure 21: EIC showing the oxidation of D on the Hypercarb analytical column with ascorbic acid added 
to the stock solution. The MP consisted of H2O/AcN added 0.1% AcOH with a flow rate of 5 µl/min and 
the injection volume was 50 nl. a,b) injection of a 0.1 mg/ml solution catecholamines, m/z = 137+154 
((a) D), m/z = 152 ((b) fragment of NE, oxidation of D); c,d) injection of a 0.1 mg/ml solution D, m/z = 
137+154 (c), m/z = 152 ((d) oxidation of D); e,f) injection of a 0.1 mg/ml solution D with the column 
disconnected, m/z = 154 (e), m/z = 152 (f).  
 
 
Inorganic reducing agents have smaller molecular masses than organic anti-oxidants. 
Therefore, interference with the analyte masses will not take place. Additionally, they ideally 
have no retention on the column. A common inorganic reducing agent is sodium thiosulphate. 
Törnkvist et al. [36] demonstrated the reduction of oxidized Hypercarb stationary phase with 
sodium thiosulphate. Alternatively, salts of the sulfurous acid, sulphite (SO32-) and bisulphite 
(hydrogensulphite, HSO3-) are powerful reducing agents and they are used to stabilize 
samples (see chapter 1.1). However, reducing power is lost in acidic solution since under 
acidic conditions primarily sulfur dioxide (SO2) exists [43, 46]. None of the research groups 
using MS detection have used sulphite or bisulphite as anti-oxidant. Thus, in this study sodium 
thiosulphate was chosen as reducing agent.  
1 mmol sodium thiosulphate was added to the A reservoir of the mobile phase (100 ml). 
The use of thiosulphate resulted in signal suppression and clogging of the capillaries rapidly 
occurred, because thiosulphate is not enough soluble in AcN. Thus it was not an alternative to 
add sodium thiosulphate to the mobile phase. 
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3.4.1.3 Improvement of the system 
 
Shibukawa and co-workers demonstrated that a cobalt-trans-1,2-
diaminocyclohexanetetraacetate (Co-DCTA) complex was oxidized on the first of two 
Hypercarb columns coupled in series [26]. Therefore, guard columns were coupled between 
the pumps and the valves (figure 2). They were oxidized by the mobile phase first, lengthening 
the life of the reduced precolumn and analytical column. Figure 22 shows the average 
retention times of the analytes during validation of the method. Three replicates of validation 
solutions at three concentration levels were injected. Including a blank at the beginning of 
each day, the number of injections performed was 10. The retention times were nearly 
constant. This indicates that by adding the guard columns the method did not suffer from 
severe oxidation for at least 10 injections. 
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Figure 22: Average retention times of analytes during validation when three replicates of validation 
solutions at three concentration levels were injected. 
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Figure 23 shows the peak areas of E in validation solution #5 when only m/z = 166+184 
(protonated molecular ion + fragment ion) is included (“E”) versus the peak areas when the 
mass of oxidized E is taken into account as well (m/z = 166+184+182+180, “E(ox)”). As can 
be seen from the figure, the increase in peak area when oxidation is taken into account is not 
high. Calculations (appendix table A7) show that a maximum of 10% higher peak area is 
obtained. Again, this indicated that the method did not suffer from severe oxidation for at least 
10 injections. Thus, oxidation was treated as negligible during validation. The pattern for E(ox) 
was the same as for E, thus neither the within- nor the between-day precisions were affected 
by oxidation. 
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Figure 23: Plot of the peak area of validation solution #5 for E (m/z = 184+166) and E(ox) (m/z = 
184+166+182+180).  
 
 
To regain their original properties, the guard columns were treated with 1 M sodium 
thiosulphate at the end of each day (once they were oxidized). Figure 24 shows the EIC of NE 
and D before and after the treatment of the column with thiosulphate. Oxidized D can be seen 
in the EIC of NE before treatment with thiosulphate, since the fragment of NE ([M+H-18]+) and 
oxidized D have the same m/z-values (m/z = 152). After the treatment with thiosulphate no 
oxidation was observed. 
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Figure 24: The effect of flushing with sodium thiosulphate. a) EIC of NE+NE-18 before flushing, 
oxidation of D is observed; b) EIC of D+D-17 before flushing; c) EIC of NE+NE-18 after flushing; d) EIC 
of D+ D-17 after flushing.   
 
Since no alternative to the fluorinated acid PFPA as ion-pairing agent was found, the method 
was validated using the loading mobile phase described in chapter 3.3.2. The mobile phase 
described in chapter 3.3.1 was used as separation mobile phase since no suitable additives 
were found to prevent oxidation.  
 
 
3.5 Injection volume 
 
When the concentration of the analytes in the sample is low, as it is expected for 
catecholamines in brain samples, high injection volumes are desirable to enhance sensitivity. 
A problem with large volume injections is column overload and breakthrough.  
Injection volumes of 25 µl, 50 µl, 100 µl and 200 µl were tested. A 250 ng/ml solution was 
used as injection solution. Because of the high concentration, peak saturating occurred and 
thus the peak areas of the C13-isotopes were used to find the optimal loop volume. Figure 25 
shows the peak area plotted against the loop volume for each catecholamine. The area was 
found from an average of 2 (100 µl) or 3 injections.  
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Figure 25: Variation of the peak area of the C13-isotopes with different loop sizes.  
The SP of both columns was Hypercarb. A sample concentration of 250 ng/ml was used. The loading 
MP consisted of H2O+0.1% PFPA with a flow rate of 50 µl/min. The separation MP consisted of 
H2O/AcN added 0.1% AcOH with a flow rate of 5 µl/min. 
 
The peak area of D, E, NE and SE increased when the injection volume was increased from 
25 µl to 50 µl and to 100 µl. A further increase of the injection volume resulted in a decrease 
of the peak area of D, E and NE, while a smaller increase of the peak area was observed for 
SE. To be sure to avoid column overload of D, E and NE, an injection volume of 100 µl was 
chosen as maximum.  
 
 
3.6 Robustness 
 
In a column-switching system several parameters can be varied to achieve high sensitivity 
and each of them has to be optimized. Parameters tested in this work were the loading flow 
rate; the reconditioning time of the precolumn with the loading mobile phase; the loading time 
of the sample on the precolumn; delay-time of the gradient e.g. the time between gradient 
start at the pump and switching time of valve II from the load to the inject position to start 
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elution from the precolumn; use of acetonitrile from three different producers; degassing of the 
mobile phase after preparation versus on-line degassing of the mobile phase during analysis.  
The guard column for the loading mobile phase (guard column II) had to be changed after 
the loop size was determined. This change resulted in an increase of the backpressure in the 
system, and it was not possible to operate with a loading flow rate of 50 µl/min. A loading flow 
of 25 µl/min had to be used in the final system.  
The delay-time was first evaluated. Figure 26 shows a chromatogram of an acquisition 
where the valve was switched at the same time as the gradient was started (no delay-time) 
and a chromatogram of an acquisition where the valve was switched 3 min after the gradient 
was started (3 min delay-time). The intensity of the NE signal is approximately 8 times lower 
and the peak is broader in the first case. NE is not entirely focused on the precolumn at the 
starting conditions of the gradient (0% B). Therefore, when the valve is switched at the same 
time as the gradient is started, NE is slowly eluted from the column. The delay-time of the 
pump, e.g. the time it takes the mobile phase to get from the pump to the column is 
approximately 3 min. Waiting 3 min thus improves the NE signal and peak shape since it is 
eluted by the gradient.  
 
 
 
Figure 26: EIC showing differences in the peak shape and the intensity for the norepinephrine peak at 
a) no delay-time; b) 3 min delay-time.  
The SP of both columns was Hypercarb. A sample concentration of 250 ng/ml was used and the 
sample loop had a volume of 100 µl. The loading MP consisted of H2O+0.1% PFPA with a flow rate of 
25 µl/min. The separation MP consisted of H2O/AcN added 0.1% AcOH with a flow rate of 5 µl/min. 
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All remaining tests were performed using a 3 min delay time and 25 µl/min loading flow. 
Figure 27 shows the peak areas plotted against different reconditioning times of the 
precolumn and different sample loading times.  
At first, the loading time was held constant at 4 min. The reconditioning time of the 
precolumn was set to 2 min in the first to runs. It was then increased to 3 min in the next two 
runs. Due to peak saturating, the peak area for D was calculated using C13-isotopes. The peak 
area increased except for NE. There is no good explanation why the peak area of NE 
decreased when the reconditioning time is increased by 1 min, since a decrease is also 
observed when oxidation is taken into account. Despite this fact, a reconditioning time of 3 
min was chosen. There after, the loading time was increased to 5 min, holding the 
reconditioning time at 3 min. In this case, an increase in the peak area was observed for all 
four analytes. Thus, the reconditioning time of the precolumn was chosen to be 3 min and the 
loading time 5 min. 
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Figure 27: Variation of peak area with different reconditioning and loading times, D: m/z = 155+138. 
The SP of both columns was Hypercarb. A sample concentration of 62.5 ng/ml was used and the 
sample loop had a volume of 100 µl. The loading MP consisted of H2O+0.1% PFPA with a flow rate of 
25 µl/min. The separation MP consisted of H2O/AcN added 0.1% AcOH with a flow rate of 5 µl/min. 
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Acetonitrile from three different producers was tested. No differences in oxidation behavior 
were observed.  
The mobile phase was degassed with He after preparation for around 15 min. On-line 
degassing with He did not increase the number of injections possible before thiosulphate 
treatment was needed.  
 
 
3.7 Validation 
 
A representative EIC for the simultaneous determination of four catecholamines using the 
developed column-switching method is shown in figure 28. A somewhat poorer resolution 
compared to the separation on the simplified system (figure 5) was obtained because of 
different lengths of the analytical columns.  
 
 
Figure 28: EIC (sum) of a separation of four catecholamines with the developed column-switching 
method.  
The precolumn was a 25 x 0.32 (i.d.) mm 5 µm Hypercarb column and the analytical column was a 34 x 
0.32 (i.d.) mm 5 µm Hypercarb column. A sample concentration of 50 ng/ml (D,E) and 60 ng/ml (NE, 
SE) was used and the sample loop had a volume of 100 µl. The loading MP consisted of H2O+0.1% 
PFPA with a flow rate of 25 µl/min. The separation MP consisted of H2O/AcN added 0.1% AcOH with a 
flow rate of 5 µl/min. 
 
The validation was carried out using the validation solutions described in table 5. 
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3.7.1 Limit of detection and limit of quantification 
 
The limit of detection (LOD) for each catecholamine was determined by the concentration 
giving a signal to noise ratio (S/N) of 3, and the limit of quantification (LOQ) giving S/N = 10. 
The limits of detection for dopamine, epinephrine, norepinephrine and serotonin for a 100 
µl injection volume were 1.5, 0.75, 3.0 and 1.5 ng/ml, respectively. Values of the mLOD, 
cLOD, mLOQ and cLOQ are given in table 10. Compared to other methods with (ESI-) MS 
detection that are described in the literature, better limits of detection were performed in the 
present study. 
 
Table 10: Limit of detection and limit of quantification. Injection volume: 100µl; loading flow: 25µ/min.  
 Dopamine Epinephrine Norepinephrine Serotonin 
mLOD [ng] 0.15  0.075  0.30  0.15  
cLOD [ng/ml] 1.5  0.75  3.0  1.5  
mLOQ [ng] 0.75  0.30  1.0  1.0  
cLOQ [ng/ml] 7.5  3.0  10  10  
 
Peterson et al. [4, 8] described a CE system with ESI-TOF detection. In their work they get 
detection limits of 45.9 ng/ml, 18.8 ng/ml, 50.7 ng/ml and 26.4 ng/ml for D, E, NE and SE, 
respectively. These detection limits are much higher (about 17 to 30 times) than the limits of 
detection obtained in this work. Another work using mass spectrometry detection was done by 
Chan and co-workers [3] and they obtained limits of detection of 5 ng/ml for D, E and NE, 
which is slightly higher than presented here. Törnkvist and co-workers use µLC with ESI-MS 
detection and got limits of detection of 0.5 ng/ml and 1.5 ng/ml for NE and D, respectively [16]. 
With electrochemical detection lower limits of detection can be obtained. He et al. 
presented a LC-EC system for determination of NE and E [15] with limits of detection of 12 
pg/ml for both compounds. Niwa and co-workers obtained a limit of detection of 1 pg/ml for D 
with their LC-EC system [14].  
 
 
3.7.2 Linearity 
 
To check the linearity one of the replicates of each validation solution was randomly chosen 
from the validation experiment. Figure 29 shows a first series of linearity curves for D, E, NE 
and SE. Linear and second degree polynomial regression lines were calculated. All correlation 
coefficients (R2-values) are given in table 11. D and E have good linear fit, although the 
polynomial fit is even better. NE and SE have poorer linear fit than D and E. The correlation is 
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greatly improved with the polynomial fit. Thus, the curves for both NE and SE are second-
degree polynomial.  
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Figure 29: Linearity curves for D, E, NE and SE using a TDC stop voltage of 100 mV. Data points are 
chosen randomly from three replicates of validation solution #1, #3 and #5. 
 
 
Table 11: Correlation coefficients for the linear and the polynomial fit at both 100 mV and 50 mV TDC-
stop voltage. 
TDC-voltage R2-values Dopamine Epinephrine Norepinephrine Serotonin 
linear 0.985 0.996 0.954 0.940 100 mV 
polynomial 0.994 0.997 0.970 0.996 
linear 0.992 0.997 0.985 0.998 50 mV 
polynomial 0.998 0.997 0.999 0.999 
 
Solbu [38] described a similar problem in his work. He obtained a linear curve by reducing the 
standard TDC stop voltage of the mass analyzer. The first series of linearity curves was 
obtained using a TDC stop voltage of 100 mV. In a second series, the TDC stop voltage was 
set to 50 mV (figure 30). Validation solutions #4 and #6 were not included in this series. All 
catecholamines showed an improved linearity, however all polynomial fits were better and 
especially the curve of NE still looks polynomial. The better polynomial fit could be explained 
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by the fact that a polynomial curve always will fit a linear curve. Since better linearity and 
better sensitivity was obtained with a TDC-stop voltage of 50 mV, the series on day 2 and day 
3 were measured with this voltage. 
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Figure 30: Linearity curves for D, E, NE and SE using a TDC stop voltage of 50 mV. Data points are 
chosen randomly from three replicates of validation solutions #1, #3 and #5. 
 
 
3.7.3 Repeatability 
 
The within-day and between-day precision of the retention times and the peak areas were 
determined on three different days using three replicates at three concentration levels. They 
were calculated by analysis of variance (ANOVA, appendix, chapter 6.3.3.2). In addition, the 
within-day precision for each concentration level on each day was calculated by Microsoft 
Excel in the conventional way (appendix, tables A8-A9). All calculations were performed using 
the series of concentration levels measured with a TDC-stop voltage of 50 mV.  
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Table 12 shows the within-day and between-day repeatability of the retention times calculated 
by ANOVA. The within-day and between-day precision of the peak areas calculated by 
ANOVA is given in table 13. All values are given as % relative standard deviation (% RSD). 
Raw-data are given in the appendix in tables A5-A6. 
 
Table 12: The within- and between-day precisions of the retention times calculated by ANOVA. 
 Concentration level (table 5) 
Dopamine 
RSD [%] 
Epinephrine 
RSD [%] 
Norepinephrine 
RSD [%] 
Serotonin 
RSD [%] 
1 2.7 3.0 5.9 3.8 
3 2.3 2.6 3.0 2.1 Within 
5 0.7 0.7 1.0 1.0 
1 2.2 2.7 1.2 1.5 
3 2.6 3.0 3.5 2.9 Between 
5 2.2 2.2 2.9 3.7 
 
The repeatability of the retention times is acceptable. 
 
Table 13: The within- and between-day precisions of the peak areas calculated by ANOVA. 
 Concentration level (table 5) 
Dopamine 
RSD [%] 
Epinephrine 
RSD [%] 
Norepinephrine 
RSD [%] 
Serotonin 
RSD [%] 
1 10 6.6 9.0 58# 
3 6.7 11 11 11 Within 
5 8.3 4.8 6.2 13* 
1 15 29 26 72# 
3 8.0 21 8.4 25 Between 
5 17 18 53 41* 
* A value that was close to be rejected by Grubbs test is included. # Integration of concentration level #1 
was difficult for serotonin due to no clear peaks. 
 
The within-day precisions of the peak areas of D, E and NE are satisfactory for all 
concentration levels. A high value for the within-day precision of SE at the lowest 
concentration level was found. At this concentration level the peaks were low and difficult to 
integrate. It was assumed this was because the injections of validation solution #1 were 
performed first each day and that the system needed more time for reconditioning. 
Generally, much higher values were obtained for the between-day precisions. The 
between-day precisions were, however, acceptable for all concentration levels of D and E. 
Slightly higher values were observed at the lowest and third concentration level of E, but no 
big differences between the days are apparent from the plot of all peak areas (figure 31).  
The value at the highest concentration level of NE is too high. This can be explained by 
the fact that the peak areas of NE were much higher on the first day than on the next two days 
for the actual concentration level (figure 31).  
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The values at the lowest and highest concentration level of SE are too high. An explanation 
for the high value at the lowest concentration level might be difficulties of integration (see 
within-day precision). At the highest concentration level of SE a possible outlier (see 
appendix, chapter 6.3.3.1) was included in the first day. The actual values are marked with *. 
This might be the reason for the high values at this concentration level both for the within- and 
the between-day precision. A slight increase in peak areas from day 1 to day 3 in 
concentration level 5 can be seen for SE, which also might be responsible for the high 
between-day variation. 
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Figure 31: Plot of the peak areas of all concentration levels during validation. The value marked with a 
red ring is a possible outlier. 
 
As can be seen from the between-day linearity test (appendix, figure A9), the peak area 
values of the fifth concentration level varied much more than in the other concentration levels. 
This fact cannot be explained by oxidation towards the end of a day, since as discussed in 
chapter 3.4.1.3 the pattern for E(ox) was the same as for E (figure 23) and thus the precisions 
are not affected by oxidation. Variations in the MS detection might be responsible for the high 
variation at this concentration level.  
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4. Conclusion 
 
The present study has shown that the developed column-switching µLC-method coupled to 
ESI-TOF-MS detection has the capability of providing fast and simultaneous determination of 
dopamine, epinephrine, norepinephrine and serotonin with limits of detections that are lower or 
at the same level as reported before. The analytes were separated in less than 5 minutes on a 
Hypercarb column and the time of one injection including reconditioning and loading times was 
22 min. The Hypercarb phase material has both advantages and limitations and precautions 
have to be taken when this material is used. Not all processes observed in this work involving 
the oxidation of the stationary phase and the analytes are understood. Further work should 
include investigation of the cause of oxidation by fluorinated acids and improvement of the 
method to obtain even better repeatability to analyze real samples (waste-fractions) from rat 
brain with high sensitivity. 
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6. Appendix 
 
 
6.1 Preliminary experiments 
 
6.1.1 Testing of five different reversed-phase columns as separation 
columns for peptides 
 
Five different reversed-phase analytical columns were tested using a mixture containing 0.1 
mg/ml of angiotensin II, bradykinin and neurotensin (all obtained from Sigma-Aldrich). 
The columns tested are shown in table A1. The Poroshell columns were obtained from 
Agilent Technologies, the Kromasil and Prontosil columns from G&T Septech AS (Kolbotn, 
Norway). The ACE column was packed in-house according to the procedure described in 
chapter 2.3. Stationary phase material was purchased from Mac-Mod Analytical Inc. (Chadds 
Fort, PA, USA). 
Injections were performed with a Valco ChemInert model C4 injection valve equipped with 
a 50 nl internal loop. A 25 µl laboratory syringe from SGE was used as injection syringe. The 
column was kept in a Mistral oven (Spark Holland, Emmen, The Netherlands). The mobile 
phase was delivered by a Hitachi L-7110 (Merck) isocratic LC pump and detection was 
performed using a Spectra 200 UV-ViS detector (Spectra-Physics, San Jose, CA, USA) 
equipped with an on-column optical cell built in-house. The detection wavelength was set to 
210 nm. The data processing unit was a Shimadzu C-R6A Chromatopac integrator. 
 
Table A1: Reversed-phase analytical columns tested. 
Type i.d. [mm] Length [cm] Pore size [Å] Particle size [µm] 
(1) Poroshell 300 SB-C18 0.3 7.5 300 5 
(2) Kromasil C18-100 0.3 5 100 3.5 
(3) ProntoSIL C18-300 0.3 5 300 3 
(4) Poroshell 300SB- C18 0.5 15 300 5 
(5) ACE 0.32 10.1 100 3.5 
 
The columns were tested with different compositions of water/AcN mobile phases, all added 
0.1% TFA. Additionally, the efficiency was checked using toluene as test substance. The first 
three of those columns were tested at higher flow rates as well. Figure A1 shows a 
representative chromatogram from the test of the reversed-phase analytical columns.  
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Figure A1: A representative chromatogram from the testing of reversed-phase columns. The column 
used was a Kromasil C18 column (500 x 0.3 (i.d.) mm, 3.5 µm). The MP consisted of 25% AcN and 0.1% 
TFA and had a flow rate of 5 µl/min. 50 nl of a solution containing 0.1 mg/ml angiotensin II, bradykinin 
and neurotensin was injected. Detection was performed at 210 nm. 
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A number of chromatographic parameters were established such as the k-value for the second 
peak, the plate number per meter, the selectivity, the asymmetry and the resolution between 
two peaks.  Figures A2 to A8 present the obtained data. 
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Figure A2: k-values of the second peak. 
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Figure A3: Plate number per meter at different MP compositions with a flow rate of 5 µl/min.  
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Figure A4: Selectivity between peak 1 and 2, and between peak 2 and 3 at different MP compositions. 
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Figure A5: Asymmetry of peaks with k-values of 2-5.  
 
 
0
5000
10000
15000
20000
25000
5µl/min 10µl/min 20µl/min 5µl/min 10µl/min 20µl/min 5µl/min 10µl/min 20µl/min
Poroshell (short) - 18% AcN Kromasil - 25% AcN Prontosil - 25% AcN
pl
at
e 
nu
m
be
r p
er
 m
et
er
 
Figure A6: Plate number per meter at different flow rates. 
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Figure A7: Resolution of the first two peaks at different flow rates.  
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Figure A8: Plate number per meter with toluene as test substance. 
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The Kromasil column and the ACE column provided the best plate numbers except at high 
flow rates (figures A3 and A6). High efficiency is desired for the analytical column in a column-
switching method. Additionally, they gave the highest k-value for the second peak and thus 
highest retention (figure A2). High retention is desirable for a precolumn in a column-switching 
method. Both columns have high efficiency when used for peptides and they have high 
selectivity (figure A4) and thus high resolution. Additionally, the Kromasil column gave low 
asymmetry values (figure A5). At high flow rates the Prontosil column is favourable due to no 
loss in efficiency and high resolution at all flow rates (figures A6-A7). 
The Kromasil or the ACE column with a mobile phase containing 23% and 20% acetonitrile 
respectively at 5 µl/min should be chosen because of the high efficiency provided under these 
conditions. If efficiency is not that important and high speed is desired, the Prontosil column 
should be chosen with a mobile phase containing 20% or 23% acetonitrile. 
 
 
6.1.2 Testing of three different reversed-phase columns as precolumns for 
focusing of polar analytes 
 
Three different reversed-phase columns were tested for their suitability as precolumns using 
two different mobile phases (table A2). The test substances that were tried to focus on the 
columns are given in table A3. A compound could be focused on the column when no 
breakthrough was observed after the mobile phase had been passed through the column for 
30 min. 
Conditions used during testing the reversed-phase precolumns are given in table A2. The 
PS-DVB column was tested with mobile phase A2/B2 only.  
 
Table A2: Conditions used when testing reversed-phase precolumns with H2O/AcN MP. 
Flow rate 5.0 µl/min; 2.0 µl/min* 
Column temperature Room temperature; 60°C* 
Mobile phases A1   = 500ml H2O  + 500 µl AcOH 
B1 (C18)  = 500ml 50%AcN + 500 µl AcOH 
B1 (Hypercarb) = 500ml AcN  + 500 µl AcOH 
A2   = 500ml H2O  + 500 µl HFBA 
B2   = 500ml 50%AcN + 500 µl HFBA 
Sample 0.1 mg/ml test substance 
Injection volume 50 nl 
Detection (+) ESI-TOF-MS 
* PS-DVB column 
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Table A3 gives a summary over all test substances that could be focused on the different 
reversed-phase precolumns under the conditions described. The numbers in brackets give the 
minimum percentage AcN that can be present in the mobile phase to get focusing of the whole 
group analytes. 
 
Table A3: Overview over possible focusing with H2O/AcN MP.   
 C18 Hypercarb 
 B1 (AcOH) B2 (HFBA) B1 (AcOH) B2 (HFBA) 
Dipeptides     
Gly-Gly No No No No 
Gly-Gly-NH2  No No No No 
Gly-Asp No No No No 
Gly-Glu No No No No 
Gly-His No No No Yes (0%) 
Gly-Tyr No No Yes (0%) - 
Lys-Lys No Yes (1%) Yes (0%) - 
Lys-Phe No Yes (1%) Yes (0%) - 
Ala-Ala - - No No 
Catecholamines     
Dopamine No No No Yes (0%) 
Epinephrine No No No Yes (0%) 
Norepinephrine No No No Yes (0%) 
Serotonin No No Yes (0%) Yes (0%) 
Other compounds     
GABA  No No No No 
Acetylcholine No No No No 
Propranolol Yes (5%) - - - 
Peptides     
Leu5-Enkephalin Yes (5%) - - - 
Met5-Enkephalin Yes (5%) - - - 
Oxytocin Yes (5%) - - - 
Bradykinin Yes (5%) - - - 
LHRH Yes (5%) - - - 
Neurotensin Yes (5%) - - - 
Angiotensin II Yes (5%) - - - 
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6.2 Mass spectrometer conditions 
 
Table A4: Advanced mass spectrometer conditions (printed from MassLynx Tune page). 
Source (ES+)  Advanced  
Capillary (V) 2800.0 RF DC Offset 1 (V) 10.0 
Sample cone (V) 15.0 RF DC Offset 2 (V) 6.0 
RF lens (V) 200.0 Aperture (V) 8.0 
Extraction cone (V) 3.0 Acceleration (V) 200.0 
Desolvation Temp (C) 100.0 Focus (V) 0.0 
Source Temp (C) 100.0 Steering (V) 0.0 
  MCP Detector (V) 2700.0 
Engineer  Pusher Cycle Time 70 
Ion Energy (V) 30.0 Pusher Frequency 14285.7143 
Tube Lens (V) 5.0   
Grid 2 (V) 65.0 Instrument configuration  
TOF Flight tube (V) 4617.0 TDC Gain Control 0.0 
Reflectron (V) 1771.0 TDC Edge Control 0.0 
Centroid Threshold 1.0 Use 4GHz TDC YES 
Min Points 2.0 Use TTP 4GHz TDC NO 
Np Multiplier 1.00 Source is Z-Spray Mk2 YES 
Resolution  4000.0   
Lock Mass 0.000 Gas Flow  
Mass Window +/- 0.100 Cone Gas Flow (l/hr) 6 
Lteff 1120.3000 Desolvation Gas Flow (l/hr) 251 
Veff 4600.0000   
TDC Start (mV) 700.0000 Vacuum Monitor  
TDC Stop (mV)  50.0000 Pirani Pressure (mbar) 2.02e0 
TDC Threshold 0.0000 Penning Pressure (mbar) 6.01e-7 
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6.3 Raw data 
 
6.3.1 Retention times and peak areas  
 
Table A5: Retention times of the catecholamines in all injected validation solutions. The values of the 
first series of the linearity test (TDC stop voltage = 100 mV) are not shown. 
Retention time [min] Day Concentration level Replicate # D E NE SE 
1 4.39 4.17 4.04 5.29 
2 4.20 3.97 3.85 5.29 1 
3 4.04 3.79 3.63 4.95 
1 4.32 4.09 3.95 5.09 
2 4.07 3.84 3.67 4.79 3 
3 4.12 3.85 3.67 4.82 
1 4.42 4.17 4.07 5.25 
2 4.34 4.10 3.99 5.12 
1 
5 
3 4.34 4.10 3.97 5.10 
1 4.37 4.12 4.02 5.20 
2 4.35 4.14 4.04 5.02 1 
3 4.22 4.00 3.94 5.20 
1 4.09 3.85 3.72 4.94 
2 4.24 4.00 3.87 5.04 3 
3 4.30 4.07 3.94 5.09 
1 4.37 4.15 4.00 5.15 
2 4.35 4.12 3.99 5.09 
2 
5 
3 4.34 4.14 3.95 5.07 
1 4.35 4.14 4.02 4.80 
2 4.27 4.07 3.95 5.29 1 
3 4.27 4.05 3.92 5.17 
1 4.29 4.07 3.92 5.09 
2 4.30 4.07 3.92 5.05 3 
3 4.29 4.05 3.92 5.04 
1 4.27 4.05 3.90 4.95 
2 4.27 4.05 3.90 4.95 
3 
5 
3 4.25 4.02 3.85 4.95 
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Table A6: Peak areas of the catecholamines in all injected validation solutions. 
Peak area Day Concentration level Replicate # D E NE SE 
1 17 18 11 0 
2 23 20 11 3 1 
3 23 27 16 7 
2 1 50 34 33 14 
1 98 78 78 25 
2 100 71 71 27 3 
3 108 76 70 32 
4 1 166 188 138 64 
1 277 331 161 116 
2 288 323 146 119 5 
3 287 295 114 120 
1° 
6 1 405 441 234 380 
1 44 31* 56 10* 
2 47 30* 55 29* 1 
3 50 29* 46 42* 
1 262 133 114 102 
2 255 125 111 104 3 
3 278 182 151 126 
1 484 655 411 130 
2 593 706 408 218 
1 
5 
3 582 665 380 240 
1 45 22* 42 14* 
2 41 24* 37 8* 1 
3 46 23* 42 14* 
1 218 181 135 87 
2 241 187 133 94 3 
3 266 187 142 110 
1 573 684 291 261 
2 583 672 273 261 
2 
5 
3 578 620 246 266 
1 36 22* 38 12* 
2 36 20* 42 11* 1 
3 47 25* 44 26* 
1 245 157 125 118 
2 270 161 133 142 3 
3 256 159 121 127 
1 534 586 241 317 
2 444 540 218 318 
3 
5 
3 446 534 214 319 
°First series of linearity test (TDC stop voltage = 100 mV). Generally, all values were integrated 
permitting smoothing of the peaks. The values marked with * were obtained without smoothing the 
peak. This was done because it was difficult to determine the peaks with smoothing. 
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Table A7: Peak areas of E and E with oxidation taken into account at the 5th concentration level; 
percentage increase of the peak area. 
Peak area Day Replicate  
Epinephrine Epinephrine + oxidation 
% increase 
1 655 705 7.6 
2 706 740 4.8 
Day 1 
3 665 730 9.8 
1 684 702 2.6 
2 672 714 6.3 
Day 2 
3 620 640 3.2 
1 591 616 4.2 
2 540 571 5.7 
Day 3 
3 534 571 6.9 
 
 
6.3.2 Between-day linearity test 
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Figure A9: Between-day linearity test. 
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6.3.3 Statistics  
 
Generally, statistics have to be used with care. Especially the use of the test for outliers 
demands rational deal with the numbers obtained. In the field of medical science unusual high 
or low values can occur due to abnormal high or low levels of the analyte in a real sample.  
In this work, no real samples were used, so the test can be used without the danger of 
changing the interpretation of the results.  
 
 
6.3.3.1 Test for outliers 
 
To test if one suspect value can be treated as an outlier, a Grubb’s test was performed. This 
test is recommended by ISO in preference to Dixon’s test (Q-test) [47]. The suspected value 
passed the Grubbs test and was thus kept, but it was close to be rejected.  
 
s
xvaluesuspected
G
−=              (A1) 
 
 
6.3.3.2 Analysis of variance (ANOVA) 
 
The analysis of variance was performed as described in [47]. ANOVA tests whether the 
difference between the sample means is too great to be explained by random errors. The 
number of samples is in this case the number of days; the number of members is in this case 
the number of replicates. ANOVA was performed using a Casio Model CFX-9850GB Plus 
calculator. It calculates the within-day and between-day variances. The relative standard 
deviations for within-day and between-day were calculated by (A2) and (A3) respectively, 
where MS is the factor mean of squares (mean of squares variation between groups = 
between-day variance), MSe is the error mean of squares (mean of squares variation within 
groups = within-day variance) and x is the overall mean.  
[ ]
x
MSRSD 100% ⋅=              (A2) 
[ ]
x
MSeRSD 100% ⋅=              (A3) 
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6.3.3.3 Within-day precision 
 
The within-day precision calculated in the conventional way, e.g. by calculating the relative 
standard deviation (RSD) from the retention times and the peak areas using Microsoft Excel is 
given in table A8 and A9. 
 
Table A8: Within-day precision of the retention times using a TDC stop voltage of 50 mV. 
  Dopamine RSD [%] 
Epinephrine 
RSD [%] 
Norepinephrine 
RSD [%] 
Serotonin 
RSD [%] 
day 1 0.2 0.2 0.2 0.2 
day 2 0.08 0.08 0.05 0.1  c level #1 
day 3 0.05 0.05 0.05 0.3 
day 1 0.1 0.1 0.2 0.2 
day 2 0.1 0.1 0.1 0.08  c level  #3 
day 3 0.01 0.01 0 0.03 
day 1 0.05 0.04 0.05 0.08 
day 2 0.02 0.02 0.03 0.04  c level  #5 
day 3 0.01 0.02 0.03 0 
 
Table A9: Within-day precision of the peak areas using a TDC stop voltage of 50 mV. 
  Dopamine RSD [%] 
Epinephrine 
RSD [%] 
Norepinephrine 
RSD [%] 
Serotonin 
RSD [%] 
day 1 6.4 3.3 11 60 
day 2 4.5 21 18 12  c level #1 
day 3 11 4.0 4.2 33 
day 1 6 4.3 7.2 29 
day 2 10 1.9 3.5 12  c level  #3 
day 3 0.9 5.2 8.4 3.1 
day 1 16 11 7.4 51* 
day 2 4.9 1.3 4.8 9.4  c level  #5 
day 3 10 5.1 6.5 0.3 
* A value that is near to be rejected by Grubbs test is included.  
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6.4 The neuron and signal submission by neurotransmitters  
 
 
Figure A10: The neuron with the synapse (enlarged) and the receptor site (enlarged). 
(http://www.ship.edu/~cgboeree/theneuron.html) 
 
 
 
